Dr. Claudia Roth, Vice President for Vetter’s department of Innovation Management, has been appointed to the Advisory Board of the Fraunhofer Institute for Manufacturing Engineering and Automation IPA in Stuttgart. Over the next two years, Dr. Roth will be active in the Process Industry business unit.

Cooperation among scientific research organizations, such as Germany’s preeminent Fraunhofer-Gesellschaft, is an integral part of Vetter's innovation management. "Sharing information with the sciences offers significant stimuli, particularly in the field of manufacturing," said Dr. Roth. "This appointment is particularly exciting since it allows me to contribute knowledge I gained as a member of the Advisory Board of the Fraunhofer Institute for Manufacturing Engineering and Automation IPA." The IPA’s Process Industry business unit researches how programs such as Industry 4.0 can be applied to processes in the pharmaceutical sector.

The fact that Vetter's innovation manager is discussing such issues with members of the IPA Advisory Board is valuable for both Vetter and the Fraunhofer-Gesellschaft. Commenting on the appointment, Dr. Michael Hilt, deputy head of Fraunhofer IPA in Stuttgart said: "Dr. Roth’s years of experience will help us better focus our development and solutions on the corporate needs of the process industry."

Vetter is currently working on securing its future due to a 360-degree process involving internal and external impulses to find new incitements. The ideas are integrated in a multi-stage innovation process which starts with a potential appraisal and ends with the possible market launch. The focus is on new manufacturing processes and technologies, additional services and innovative application systems to increase customer value.

Dr. Claudia Roth, who holds a diploma in Process engineering, has been with Vetter since many years. As a specialist in development she has played a major role in setting up the Vetter Development Service. She also headed up Vetter Development Service Chicago, USA, from 2009 to 2014.

About Vetter
Vetter is a global leader in the fill and finish of aseptically prefilled syringe systems, cartridges and vials. Headquartered in Ravensburg, Germany, the company operates production facilities in Germany and the United States, as well as sales offices in Singapore and Tokyo, Japan. The contract development and manufacturing organization (CDMO) is an innovative solution provider serving small, midsize, and the top 10 (bio-)pharmaceutical companies. Its portfolio spans state-of-the-art manufacturing from early clinical development through commercial filling and final packaging of parenteral drugs. Known for quality, the company of approximately 4,100 employees offers a foundation of experience spanning more than 35 years, including dozens of customer product approvals for novel compounds. More than 80% of Vetter’s active projects are biologics, and Vetter currently manufactures five of the world’ top 10. The CDMO is also committed to patient safety and compliance with user friendly solutions such as Vetter-Ject®, as well as its dual-chamber syringe Vetter Lyo-Ject® and cartridge system V-LK®.

About Fraunhofer IPA
With nearly 1 000 employees, the Fraunhofer Institute for Manufacturing Engineering and Automation IPA, Fraunhofer IPA, is one of the largest institutes in the Fraunhofer-Gesellschaft. It has an annual budget of approximately 64,2 million euros, of which more than one third derives from industrial projects. The institute’s research focus is on organizational and technological aspects of production. We develop, test and implement not only components, devices and methods, but also entire machines and manufacturing plants. Our 14 departments are coordinated via six business units, which together conduct interdisciplinary work with the following industries: automotive, machinery and equipment industry, electronics and microsystems, energy, medical engineering and biotechnology as well as process industry. The research activities of Fraunhofer IPA aim at the economic production of sustainable and personalized products. We regard cyber-physical production processes as topics of the future.